Literature DB >> 32159797

Potent Inhibitors of Organic Anion Transporters 1 and 3 From Natural Compounds and Their Protective Effect on Aristolochic Acid Nephropathy.

Caiyu Li1, Xue Wang1, Yajuan Bi1, Heshui Yu2, Jing Wei1, Yi Zhang2, Lifeng Han2, Youcai Zhang1.   

Abstract

Organic anion transporters 1 and 3 (OAT1 and OAT3) play a critical role in renal drug-drug interactions and are involved in the nephrotoxicity of many anionic xenobiotics. To date, relatively little is known about the interaction of natural compounds with OAT1 and OAT3. Of the 270 natural compounds screened in the present study, 21 compounds inhibited OAT1 and 45 compounds inhibited OAT3. Further concentration-dependent studies identified 7 OAT1 inhibitors and 10 OAT3 inhibitors with IC50 values of <10 μM, and most of them were flavonoids, the most commonly ingested polyphenolic compounds in the diet and herbal products. Computational modeling of OAT1 and OAT3 revealed the important residues for the recognition of inhibitors. The two strong OAT inhibitors, namely wedelolactone and wogonin, were evaluated for their in vivo interactions with the OAT substrate aristolochic acid I (AAI), a natural compound causing aristolochic acid-induced nephropathy (AAN) in many species. The cytotoxicity of AAI increased in two OAT-overexpressing cell lines, with more cytotoxicity in OAT1-overexpressing cells, suggesting a more important role of OAT1 than OAT3 in AAN. Both wedelolactone and wogonin markedly increased serum AAI concentrations in AAI-treated rats and ameliorated kidney injuries in AAI-treated mice. To conclude, the present findings are of significant value in understanding natural compound-drug interactions and provide a natural source for developing treatments for AAN.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  aristolochic acid; natural compound; organic anion transporter; wedelolactone; wogonin

Mesh:

Substances:

Year:  2020        PMID: 32159797     DOI: 10.1093/toxsci/kfaa033

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  5 in total

1.  Aristolochic acid-induced nephropathy is attenuated in mice lacking the neutral amino acid transporter B0AT1 (Slc6a19).

Authors:  Aleix Navarro Garrido; Young Chul Kim; Yuji Oe; Haiyan Zhang; Maria Crespo-Masip; Helen A Goodluck; Sadhana Kanoo; Paul W Sanders; Stefan Bröer; Volker Vallon
Journal:  Am J Physiol Renal Physiol       Date:  2022-08-18

2.  Computational Design of Novel Allosteric Inhibitors for Plasmodium falciparum DegP.

Authors:  Sadaf Shehzad; Rajan Pandey; Pawan Malhotra; Dinesh Gupta
Journal:  Molecules       Date:  2021-05-07       Impact factor: 4.411

3.  Oral Proteasomal Inhibitors Ixazomib, Oprozomib, and Delanzomib Upregulate the Function of Organic Anion Transporter 3 (OAT3): Implications in OAT3-Mediated Drug-Drug Interactions.

Authors:  Yunzhou Fan; Zhengxuan Liang; Jinghui Zhang; Guofeng You
Journal:  Pharmaceutics       Date:  2021-02-28       Impact factor: 6.321

4.  Therapeutic effects and mechanisms of N-(9,10-anthraquinone-2-ylcarbonyl) xanthine oxidase inhibitors on hyperuricemia.

Authors:  Tianshu Gao; Jin Xu; Yuxiao Xiao; Jiaqi Li; Weifeng Hu; Xiaoyu Su; Xudong Shen; Wan Yu; Zhen Chen; Baosheng Huang; Honglei Li; Xing Wang
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

5.  Single-Nucleus RNA Sequencing Identifies New Classes of Proximal Tubular Epithelial Cells in Kidney Fibrosis.

Authors:  Yueh-An Lu; Chia-Te Liao; Rachel Raybould; Bnar Talabani; Irina Grigorieva; Barbara Szomolay; Timothy Bowen; Robert Andrews; Philip R Taylor; Donald Fraser
Journal:  J Am Soc Nephrol       Date:  2021-06-21       Impact factor: 14.978

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.